top of page


Selected Peer-Reviewed

Endocarditis - Diagnosis and Treatment

By: Peter Magnusson, Joseph V. Pergolizzi, Payam Behzadi, and Jo Ann LeQuang. 10.5772/intechopen.100932, Nov 8, 2023. ISBN978-1-80356-741-9

Ultralow energy cardioversion in a pig model of atrial fibrillation: A feasibility study

Abdelmotagaly Elgalad, MD, PhD,* Angel Moctezuma-Ramirez, MD,*Cristiano de Oliveira Cardoso, MD, PhD,* Mathews John, MBE,† Joseph Pergolizzi, MD,‡Randall K. Wolf, MDx

From the *Center for Preclinical Surgical & Interventional Research, Texas Heart Institute, Houston, Texas, †Electrophysiology Clinical Research & Innovations, Texas Heart Institute, Houston, Texas, ‡NativeCardio Inc., Naples, Florida, and xDeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.


The Subcutaneous Implantable Cardioverter-Defibrillator

By: Peter Magnusson, Joseph V. Pergolizzi and Jo Ann LeQuang


Atrial Fibrillation and the Role of Thumb ECGs

Peter Magnusson, Magnus Samuelsson, Joseph V. Pergolizzi, Hani Annabi,  and Jo Ann LeQuang




NOAC (Novel or non-vitamin-K antagonists ) in Patients with a Single CHA2DS2-VASc Risk Factor

Joseph V Pergolizzi Jr ... Magnusson P, Pergolizzi J Jr., Wolf RK, Lamberts M, LeQuang JA (2019) Anticoagulation in Atrial ... Intech Open.



Postoperative Pain Control Following Cardiac Implantable Electronic Device Implantation

By: Peter Magnusson, Jo Ann LeQuang, and Joseph V. Pergolizzi.

'IntechOpen' DOI:10.5772/intechopen.101517


Anticoagulation in Atrial Fibrillation Patients

By: Peter Magnusson, Joseph V. Pergolizzi, Randall K. Wolf, Morten Lamberts, and Jo Ann LeQuang

DOI: 10.5772/intechopen.88965 IntechOpen


Sudden Cardiac Death: Chapter Four: the Wearable Cardioverter Defibrillator

By: Peter Magnusson, Jo Ann LeQuang, Joseph V. Pergolizzi,

White Paper


Request this White Paper

To Request this White Paper please contact us below

bottom of page